Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research

REFERENCES

• American Medical Association. (2010). The state-level economic impact of office-based physicians. Retrieved from http://www.ama-assn.org/resources/ doc/arc/economic-impact/economic-impact-report.pdf
   Google Scholar
• Baehren, D. F., Marco, C. A., Droz, D. E., Sinha, S. S., Callan, E. M., & Akpunonu, B. S. (2010). A statewide prescription monitoring program affects emergency department prescribing behaviors. Annals of Emergency Medicine, 56(1), 19–23.
   PubMed Web of Science ®Google Scholar
• Barrett, K., & Watson, A. (2005). Physician perspectives on a pilot prescription monitoring program. Journal of Pain & Palliative Care Pharmacotherapy, 19(3), 5–13.
   PubMedGoogle Scholar
• Civic Federation. (2009). Medicaid prescription drug abuse alleged in Illinois and other states. Retrieved from http://www.civicfed.org/iifs/blog/medicaid-prescription-drug-abuse-alleged-illinois-and-other-states
   Google Scholar
• Justia US Law. (2009). Iowa code title 4—public health subtitle 3—health-related professions chapter 155A—pharmacy 155A.23—prohibited acts. Retrieved from http://law.justia.com/codes/iowa/2009/title-4/subtitle-3/chapter-155a/155a-23/
   Google Scholar
• Kaiser Family Foundation. (2011). United States: Total nurse practitioners, 2010. Retrieved from http://www.statehealthfacts.org/profileind.jsp?ind = 773&cat = 8&rgn = 1
   Google Scholar
• Manchikanti, L., & Singh, A. (2008). Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician, 11, S63–S88.
   PubMed Web of Science ®Google Scholar
• National Alliance For Model State Drug Laws. (2011). Practitioner education in the utilization prescription monitoring program data. Retrieved from http://www.namsdl.org/documents/PractitionerLiability-NatPMPMtg-6-8-11.pdf
   Google Scholar
• National Institute on Drug Abuse. (n.d.) The basics: The science of drug use and addiction. Retrieved from http://drugabuse.gov/mediaguide/scienceof.html
   Google Scholar
• National Substance Abuse Index. (n.d.). Federal drug classification schedules. Retrieved from http://nationalsubstanceabuseindex.org/drugclass.htm
   Google Scholar
• Office of Naional Drug Control Policy. (2006). Synthetic drug control strategy. Retrieved from http://dhs.alabama.gov/pdf/info/synthetic_strategy.pdf
   Google Scholar
• Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine, 12, 747–754.
   PubMed Web of Science ®Google Scholar
• Pradel, V., Frauger, E., Thirion, X., Ronfle, E, Lapierre, V., Masut, A. L., Coudert, C., Blin, O., & Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dose buprenorphine. Pharmacoepidemiology and Drug Safety, 18(1), 36–43.
   PubMed Web of Science ®Google Scholar
• Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficiency. Substance Abuse: Research and Treatment, 3, 41–51.
   PubMedGoogle Scholar
• Ross-Degnan, D., Simoni-Wastila, L., Brown, J. S., Gao, X., Mah, C., Cosler, L. E., Fanning, T., Gallagher, P., Salzman, C., Shader, R. I., Inui, T. S., & Soumerai, S. B. (2004). A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. International Journal of Psychiatry in Medicine, 34(2), 103–123.
   PubMed Web of Science ®Google Scholar
• Simeone, R., & Holland, L. (2006). An evaluation of prescription drug monitoring programs. Retrieved from http://pmpexcellence.org/pdfs/ simeone_pdmp_eval2_2006.pdf
   Google Scholar
• Simoni-Watsila, L., Ross-Degnan, D., Mah, C., Gao, X., Brown, J., Cosler, L. E., Fanning, T., Gallagher, P., Salzman, C., & Soumerai, S. B. (2004). A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in Medicaid patients with chronic psychiatric and neurologic disorders. Clinical Therapeutics, 26(2), 322–336.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (HHS Publication No. SMA 10–4586). Rockville, MD: Office of Applied Studies.
   Google Scholar
• Substance Abuse Policy Research Program. (no date) Policy brief: Substance abuse benefits and costs. Retrieved from http://www.saprp.org/ knowledgeassets/knowledge_brief.cfm?KAID = 1
   Google Scholar
• Tennessee Medical Association. (2009). Doctor shopping in Tennessee: A prescriber's responsibility under Tennessee law. Retrieved from http:// www.tnmed.org/uploadedFiles/Stay_Informed/Resources/Legal_Resources/ DocShopping.pdf
   Google Scholar
• Ulbrich, T. R., Dula Clark, C. A., Green, C. G., Porter, K., & Bennett, M. S. (2010). Factors influencing community pharmacists’ enrollment in a state prescription monitoring program. Journal of the American Pharmacists Association, 50(5), 588–594.
   PubMed Web of Science ®Google Scholar
• University of Kentucky Institute for Pharmaceutical Outcomes and Policy. (2010). Review of prescription drug monitoring programs. Retrieved from http://chfs.ky.gov/NR/rdonlyres/85989824-1030-4AA6-91E1-7F9E3EF- 68827/0/KASPEREvaluationPDMPStatusFinalReport6242010.pdf
   Google Scholar
• U.S. Center for Disease Control. (2010). Number of poisoning deaths involving opioid analgesics and other drugs or substances—United States, 1999–2007. Morbidity and Mortality Weekly Report, 59(32), 1026.
   Google Scholar
• U.S. Department of Health and Human Services. (2009). Cost offset of treatment services. Retrieved from http://www.samhsa.gov/grants/ CSAT-GPRA/general/SAIS_GPRA_CostOffsetSubstanceAbuse.pdf
   Google Scholar
• U.S. Department of Justice Drug Enforcement Agency. (no date). Controlled substance schedules. Retrieved from http://www.deadiversion. usdoj.gov/schedules/
   Google Scholar
• U.S. Department of Justice Drug Enforcement Agency. (2009). Facts about prescription drug diversion and abuse. Retrieved from http://www.justice. gov/dea/concern/prescription_drug_fact_sheet.html
   Google Scholar
• U.S. Government Accountability Office. (2011). Medicare Part D: Instances of questionable access to prescription drugs. Retrieved from http://www.scribd.com/doc/67614641/GAO-Report-on-Medicare-Part-D
   Google Scholar
• Wang, J. & Christo, P. J. (2009). The influence of prescription monitoring programs on chronic pain management. Pain Physician, 12, 507–515.
   PubMed Web of Science ®Google Scholar
• Wilsey, B. L., Fishman, S. M., Gilson, A. M., Casamalhuapa, C., Baxi, H., Lin, T. S., & Li, C. S. (2011). An analysis of the number of multiple prescribers for opioids utilizing data from the California prescription monitoring program. Pharmacoepidemiology and Drug Safety. doi: 10.1002/pds. 2129
   PubMed Web of Science ®Google Scholar
• Wilsey, B. L., Fishman, S. M., Gilson, A. M., Casamalhuapa, C., Baxi, H., Zhang, H., & Li, C. S. (2010). Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorexics. Drug and Alcohol Dependence, 112(1–2), 99–106.
   PubMed Web of Science ®Google Scholar